Efficacy of low-fat milk and yogurt fortified with vitamin D3 on systemic inflammation in adults with abdominal obesity
Payam Sharifan, Mohammad Rashidmayvan, Zahra Khorasanchi, Susan Darroudi, Azam Heidari, Fatemeh Hoseinpoor, Hassan Vatanparast, Mohammad Safarian, Saeid Eslami, Asma Afshari, Zahra Asadi, Hamideh Ghazizadeh, Mohammad Bagherniya, Hamed Khedmatgozar, Gordon A. Ferns, Mitra Rezaie, Majid Ghayour‐Mobarhan
Abstract
Abstract Background The prevalence of vitamin D deficiency is increasing globally and is associated with an increased risk of metabolic syndrome, autoimmune disease, and cardiovascular disease. Vit D deficiency is also associated with increased systemic inflammation. The current study aimed to determine the efficacy of low-fat milk and yogurt fortified with 1500 IU nano-encapsulated vitamin D, on systemic inflammation in abdominal obese participants. Method This multi-center study was conducted using a 2.5-month parallel total-blind randomized clinical trial design. Two hundred and eighty nine subjects were allocated to four groups: low-fat milk fortified by 1500 IU nano-encapsulated vitamin D 3 (200 mL/day). Simple milk (200 mL/day), low-fat yogurt fortified by 1500 IU nano-encapsulated vitamin D 3 (150 g/day), and simple yogurt (150 g/day). Results The results showed that serum levels of neutrophils, lymphocytes, platelets and red blood cell distribution width (RDW) were significantly lower before and after the intervention in fortified dairy groups. The results showed that serum levels of neutrophils, lymphocytes, platelets, and RDW before and after intervention in the fortified dairy groups were significantly lower ( p < 0.05). The values of = neutrophil to lymphocyte ratio (NLR), platelets to lymphocyte ratio, and RDW to platelets ratio (RPR) reduced significantly in the fortification group ( p < 0.05). Conclusion Fortification with nano-encapsulated vitamin D 3 of dairy products may decrease inflammation in individuals with abdominal obesity.